HJHossein Jafari-Nodoushan

Hossein Jafari-Nodoushan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hossein Jafari-Nodoushan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Mohammad Ali Faramarzi

    Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Nasrin Samadi

    Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Somayeh Mojtabavi

    Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran 1417614411, Islamic Republic of Iran

    2 shared publications
  • Ali Mohamad Ranjbar

    Department of pharmacognosy, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

    1 shared publication
  • Alieh Ameri

    Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Islamic Republic of Iran

    1 shared publication
  • Amir Reza Abdollahi

    Department of Drug and Food Control Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran tums.ac.ir

    1 shared publication

Latest Publications

  • Open Access

    When the Medium Skews the Message: Commercial Mueller–Hinton Agar Media and Their Effect on Antibiogram Results of Imipenem, Ciprofloxacin, and Gentamicin Against Standard and Clinical Strains of Pseudomonas aeruginosa

    by Amir Reza Abdollahi, Seyed Sadeq Mousavi Ghahfarrokhi, Fatemeh Aghajafari, Hossein Jafari-Nodoushan, Marjan Tootianquds, Nasrin Samadi

    Accurate antimicrobial susceptibility testing (AST) is essential for guiding effective therapy and monitoring antibiotic resistance, particularly for Pseudomonas aeruginosa , a pathogen noted for its intrinsic and adaptive resistance mechanisms. Mueller–Hinton agar (MHA) is the standard medium for AST; however, variations in its composition among commercial brands can significantly affect test outcomes. This study evaluated the influence of five different commercial MHAs (HiMedia, Merck, Condalab, Quelab, and Sigma) on the antibiogram results of imipenem, ciprofloxacin, and gentamicin against both standard ( P. aeruginosa ATCC 15442) and 50 clinical isolates. Three inoculation methods, swab, pour plate, and double‐layer, were compared with identify the most reproducible approach. Inductively coupled plasma mass spectrometry (ICP‐MS) was used to quantify divalent cations (Ca 2+ , Mg 2+ , Zn 2+ , Mn 2+ , Fe 2+ ) in each medium, and microscopic examination assessed gel microstructure. The double‐layer method demonstrated the lowest coefficient of variation, indicating superior reproducibility compared with the swab and pour plate techniques. Significant differences were observed among media in inhibition zone diameters, with Quelab and Condalab producing consistently smaller zones ( p < 0.05). Cation analysis revealed wide variability, with calcium and magnesium levels differing up to fourfold across brands and being associated with differences in antibiotic activity, particularly for gentamicin and ciprofloxacin. Microscopic evaluation revealed minor gel‐structure variations without measurable impact on antibiotic diffusion. Susceptibility profiles also differed among MHA brands. These findings highlight the potential importance of medium composition, particularly cation concentration, in the variability of AST results. Standardization and rigorous quality control of commercial MHAs are essential to ensure reliable, reproducible, and clinically meaningful susceptibility testing.

  • A survey on the stabilizing effect of osmolytes on the ultrasound-irradiated lipase for efficient enzymatic hydrolysis of coconut oil

    by Somayeh Mojtabavi, Maxime Hervé, Hamid Forootanfar, Hossein Jafari-Nodoushan, Ghazal Sharifian, Nasrin Samadi, Alieh Ameri, Mohammad Ali Faramarzi


  • Open Access

    Instantaneous synthesis and full characterization of organic–inorganic laccase-cobalt phosphate hybrid nanoflowers

    by Khashayar Vojdanitalab, Hossein Jafari-Nodoushan, Somayeh Mojtabavi, Mahtab Shokri, Hoda Jahandar, Mohammad Ali Faramarzi

    A novel approach termed the "concentrated method" was developed for the instant fabrication of laccase@Co3(PO4)2•hybrid nanoflowers (HNFs). The constructed HNFs were obtained by optimizing the concentration of cobalt chloride and phosphate buffer to reach the highest activity recovery. The incorporation of 30 mM CoCl2 and 160 mM phosphate buffer (pH 7.4) resulted in a fast anisotropic growth of the nanomaterials. The purposed method did not involve harsh conditions and prolonged incubation of precursors, as the most reported approaches for the synthesis of HNFs. The catalytic efficiency of the immobilized and free laccase was 460 and 400 M−1S−1, respectively. Also, the enzymatic activity of the prepared biocatalyst was 113% of the free enzyme (0.5 U mL−1). The stability of the synthesized HNFs was enhanced by 400% at pH 6.5–9.5 and the elevated temperatures. The activity of laccase@Co3(PO4)2•HNFs declined to 50% of the initial value after 10 reusability cycles, indicating successful immobilization of the enzyme. Structural studies revealed a 32% increase in the α-helix content after hybridization with cobalt phosphate, which improved the activity and stability of the immobilized laccase. Furthermore, the fabricated HNFs exhibited a considerable ability to remove moxifloxacin as an emerging pollutant. The antibiotic (10 mg L−1) was removed by 24% and 75% after 24 h through adsorption and biodegradation, respectively. This study introduces a new method for synthesizing HNFs, which could be used for the fabrication of efficient biocatalysts, biosensors, and adsorbents for industrial, biomedical, and environmental applications.


  • Open Access

    Formulation and Optimization of Oral Mucoadhesive Patches of Myrtus Communis by Box Behnken Design

    by Mahbubeh Hashemi, Vahid Ramezani, Mohammad Seyedabadi, Ali Mohamad Ranjbar, Hossein Jafari, Mina Honarvar, Hamed Fanaei

    Purpose: Recurrent aphthous stomatitis (RAS) is the most common painful ulcerative disease of oral mucosa happening in ~20% of people. Aimed to develop Myrtus communis L. (Myrtle) containing oral patches, we applied box-behnken design to evaluate the effect of polymers such as Polyvinyl pyrrolidone (PVP), Gelatin, Methylcellulose (MC) and Pectin. Methods: The patches properties such as tensile strength, folding endurance, swelling index, thickness, mucoadhesive strength and the pattern of myrtle release were evaluated as dependent variables. Then, the model was adjusted according to the best fitted equation with box behnken design. Results: The results indicated that preparation of myrtle patch with hydrophilic polymers showed the disintegration time up to 24h and more. Using of polyvinyl pyrrolidone as a water soluble polymer and a pore-former polymer led to faster release of soluble materials from the patch to 29 (min-1). Also it decreases swelling index by increasing the patch disintegration. Gelatin and Pectin, with rigid matrix and water interaction properties, decreased the swelling ratio. Pectin increased the tensile strength, but gelatin produced an opposite effect. Thinner Myrtle patch (about 28µm) was obtained by formulation of methyl cellulose with equal ratio with polyvinyl pyrrolidone or gelatin. Conclusion: Altogether, the analysis showed that the optimal formulation was achieved with of 35.04 mg of Gelatin, 7.22 mg of Pectin, 7.20 mg of polyvinyl pyrrolidone, 50.52 mg of methyl cellulose and 20 mg of Myrtle extract.